Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Sir Dave Stuart, FRS FMedSci, NDM’s Professor of Structural Biology, knighted for services to medical research and the scientific community.

Professor Sir Dave Stuart

Dave is the Founder and Director of the Division of Structural Biology (STRUBI) and Oxford Centre for EM imaging of Infectious Particles (OPIC) and Life Sciences’ Director at the Diamond Light Source. His work ranges across virus-receptor interactions, basic puzzles of virus assembly and studying virus evolution. He has made numerous contributions to the understanding of the structure of viruses, structural vaccinology and anti-viral drug discovery. 

Over the last year, he has led a huge collaborative effort between Diamond, Rosalind Franklin Institute and the University of Oxford studying the structures of SARS-Cov-2 protein structures, and particularly the interaction of the virus’ Spike receptor protein with patient-derived antibodies. This knowledge is being used in anti-COVID19 drug development and tracking and evaluating the significance of new variants. All this work draws heavily on national and international collaborations with academic and industrial partners. Dave has also helped to develop and establish the high-throughput anti-COVID19 antibody screening platform in NDM, which is used by the Office of National Statistics to screen the UK population.

Similar stories

RECOVERY Trial identifies another effective COVID-19 treatment

The RECOVERY Trial, the world’s largest randomised trial of potential COVID-19 treatments, has found that a monoclonal antibody combination developed by US company Regeneron reduces deaths for hospitalised COVID-19 patients who have not mounted their own immune response.

NDM Researchers recognised in Queen’s Birthday Honours

The pioneering work of members of the University, including research into tackling the Coronavirus pandemic, has been recognised in The Queen's Birthday Honours List.

University of Oxford to launch Pandemic Sciences Centre

The University of Oxford has today announced the launch of a new centre of global research collaboration and excellence, the Pandemic Sciences Centre. The Pandemic Sciences Centre will harness the strong global research collaborations that the University of Oxford has developed over more than forty years. Its mission will be to ensure that the world is better equipped to create global, and equitable science-driven solutions to prepare for, identify, and counter future pandemic threats.

RECOVERY trial named David Sackett Trial of the Year 2020

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has been named David Sackett Trial of the Year by the Society for Clinical Trials (SCT). The award was presented today at the Society for Clinical Trials’ 42nd Annual Meeting.

Oxford University and Oracle partner to speed identification of COVID-19 variants

The partnership will enable global genomic sequencing and examination through a specialist platform developed on Oracle Cloud Infrastructure to help mitigate the impact of potentially dangerous COVID-19 variants.

Five new Academy of Medical Sciences Fellows from NDM

The Academy of Medical Sciences has elected 11 University of Oxford biomedical and health scientists to its fellowship five of which are from the Nuffield Department of Medicine. All were selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.